$39.04
Insights on Blackrock Health Sciences Trust
Revenue is up for the last 2 quarters, 1.96M → 18.29M (in $), with an average increase of 89.2% per quarter
Netprofit is up for the last 2 quarters, 4.35M → 8.70M (in $), with an average increase of 50.0% per quarter
In the last 1 year, Kkr & Co. L.p. has given 88.6% return, outperforming this stock by 96.5%
In the last 3 years, Apollo Asset Management Inc has given 70.7% return, outperforming this stock by 90.3%
0.1%
Downside
Day's Volatility :0.64%
Upside
0.54%
11.83%
Downside
52 Weeks Volatility :18.59%
Upside
7.66%
Period | Blackrock Health Sciences Trust | Russel 2000 | Index (Russel 2000) |
---|---|---|---|
3 Months | -4.71% | 0.0% | 0.0% |
6 Months | 9.05% | 0.0% | 0.0% |
1 Year | -7.9% | 2.2% | 2.2% |
3 Years | -19.62% | -23.0% | -23.0% |
Market Capitalization | 548.0M |
Book Value | $42.18 |
Dividend Share | 2.556 |
Dividend Yield | 6.5% |
Earnings Per Share (EPS) | 1.44 |
PE Ratio | 27.29 |
PEG Ratio | 0.0 |
Profit Margin | 244.3% |
Operating Margin TTM | 21.14% |
Return On Assets TTM | 0.21% |
Return On Equity TTM | 3.37% |
Revenue TTM | 8.2M |
Revenue Per Share TTM | 0.59 |
Quarterly Revenue Growth YOY | -0.8% |
Gross Profit TTM | 7.7M |
Diluted Eps TTM | 1.44 |
Quarterly Earnings Growth YOY | -0.76 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Sell
Neutral
Buy
Blackrock Health Sciences Trust is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Blackrock Health Sciences Trust | -4.83% | 9.05% | -7.9% | -19.62% | 3.55% |
Blackstone Inc | -3.53% | 33.65% | 44.6% | 41.65% | 206.94% |
Kkr & Co. L.p. | -6.12% | 73.85% | 88.61% | 70.72% | 286.28% |
Blackrock, Inc. | -7.63% | 24.8% | 16.44% | -7.41% | 58.18% |
Apollo Asset Management Inc | -1.76% | 38.09% | 82.27% | 105.17% | 240.16% |
Brookfield Corp | -1.9% | 34.59% | 29.9% | -11.41% | 25.59% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Blackrock Health Sciences Trust | 27.29 | 27.29 | 0.0 | 0.0 | 0.03 | 0.0 | 0.07 | 42.18 |
Blackstone Inc | 43.74 | 43.74 | 1.75 | 4.77 | 0.21 | 0.09 | 0.03 | 9.63 |
Kkr & Co. L.p. | 23.66 | 23.66 | 1.3 | 4.8 | 0.09 | 0.02 | 0.01 | 25.83 |
Blackrock, Inc. | 19.38 | 19.38 | 2.46 | 41.27 | 0.14 | 0.03 | 0.03 | 264.96 |
Apollo Asset Management Inc | 13.61 | 13.61 | 1.37 | 7.73 | 0.32 | 0.02 | 0.02 | 22.27 |
Brookfield Corp | 66.44 | 66.44 | NA | 4.72 | 0.03 | 0.02 | 0.01 | 27.36 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Blackrock Health Sciences Trust | NA | $548.0M | 3.55% | 27.29 | 244.3% |
Blackstone Inc | Buy | $150.7B | 206.94% | 43.74 | 21.68% |
Kkr & Co. L.p. | Buy | $86.1B | 286.28% | 23.66 | 20.0% |
Blackrock, Inc. | Buy | $113.5B | 58.18% | 19.38 | 32.26% |
Apollo Asset Management Inc | Buy | $64.0B | 240.16% | 13.61 | 15.8% |
Brookfield Corp | Buy | $61.5B | 25.59% | 66.44 | 1.15% |
In the quarter ending March,2024. Blackrock Health Sciences Trust has declared dividend of $0.21
Read Moreblackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelines
Organization | Blackrock Health Sciences Trust |
Employees | 0 |
CEO | Mr. Charles Choon Sik Park |
Industry | Miscellaneous |